Badanie leczenia łysienia czołowego z użyciem mikronakłuwania i terapii fotodynamicznej z kwasem 5-aminolewulinowym u dorosłych mężczyzn i kobiet

Frontal fibrosing alopecia (FFA) is a condition that causes hair loss, mainly affecting the front of the scalp. This study is focused on treating FFA using a combination of microneedling and photodynamic therapy. Microneedling involves using tiny needles to create small punctures in the skin, which can help stimulate hair growth. Photodynamic therapy uses a special light and a cream called Metvix, which contains the active ingredient methyl aminolevulinate hydrochloride, to reduce inflammation and promote healing.

The purpose of the study is to see if this treatment can reduce inflammation caused by FFA over a period of 32 weeks. Participants will receive the treatment and be monitored to assess changes in their condition. The study will track improvements in symptoms such as redness and skin thickening, as well as changes in hair density. The treatment is applied directly to the skin, and the study will evaluate its effectiveness in both men and women who are 18 years or older.